To the top

Page Manager: Webmaster
Last update: 9/11/2012 3:13 PM

Tell a friend about this page
Print version

Toxicokinetics of mercury… - University of Gothenburg, Sweden Till startsida
Sitemap
To content Read more about how we use cookies on gu.se

Contact form








 


Note! If you want an answer on a question you must specify your email address




Toxicokinetics of mercury after long-term repeated exposure to thimerosal-containing vaccine.

Journal article
Authors Lars Barregård
Dinko Rekić
Milena Horvat
Lisa Elmberg
Thomas Lundh
Olof Zachrisson
Published in Toxicological sciences : an official journal of the Society of Toxicology
Volume 120
Issue 2
Pages 499-506
ISSN 1096-0929
Publication year 2011
Published at Institute of Medicine, School of Public Health and Community Medicine
Institute of Neuroscience and Physiology, Department of Psychiatry and Neurochemistry
Institute of Neuroscience and Physiology, Department of Pharmacology
Pages 499-506
Language en
Links dx.doi.org/10.1093/toxsci/kfr009
Keywords Adult, Aged, Clinical Trials as Topic, Female, Half-Life, Humans, Injections, Subcutaneous, Male, Mercury, blood, toxicity, Methylmercury Compounds, blood, toxicity, Middle Aged, Preservatives, Pharmaceutical, chemistry, pharmacokinetics, Staphylococcal Toxoid, administration & dosage, chemistry, pharmacokinetics, Thimerosal, blood, chemistry, pharmacokinetics, Time Factors
Subject categories Toxicology

Abstract

The preservative thimerosal contains ethyl mercury (EtHg). Concerns over possible toxicity have re-emerged recently due to its presence in (swine and other) flu vaccines. We examined the potential accumulation of mercury in adults given repeated injections of a thimerosal-preserved vaccine for many years. Fifteen female patients were recruited from an outpatient clinic running a clinical trial with repeated injections (1 ml every 3-4 weeks) of a staphylococcus toxoid vaccine containing 0.01% thimerosal to treat chronic fatigue syndrome. Fifteen untreated female patients with the same diagnoses served as controls. Blood samples were taken before injecting the vaccine, 1 day later, about 2 weeks later, and just before the next injection. In the 15 controls, samples were taken twice. Blood was analyzed for total mercury and EtHg. The toxicokinetics were assessed for each patient separately as well as with a population-based pharmacokinetic model. Total mercury in blood increased on Day 1 in all treated patients (median: 0.33, range: 0.17-1.3 μg/l), as did EtHg (median: 0.14 μg/l, range: 0.06-0.43 μg/l). After a few weeks, levels were back to normal and similar to those in controls. Levels of methyl mercury (MeHg; from fish consumption) were much higher than those of EtHg. After exclusion of an outlier, the mean half-life in a population-based model was 5.6 (95% CI: 4.8-6.3) days. The results indicate that mercury from thimerosal is not accumulated in blood in adults. This is in accordance with short half-lives and rapid metabolism of EtHg to inorganic mercury.

Page Manager: Webmaster|Last update: 9/11/2012
Share:

The University of Gothenburg uses cookies to provide you with the best possible user experience. By continuing on this website, you approve of our use of cookies.  What are cookies?